Preview

Chemotherapy Practice Competencies

Good Essays
Open Document
Open Document
963 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Chemotherapy Practice Competencies
It is essential the nurse administering chemotherapy have completed a recognised training and assessment course, as per Cancer Care Alliance (CCA) chemotherapy education policy (2006), In 1998 The Royal College of Nursing (RCN) produced clinical practice guidelines in the administration of cytotoxic chemotherapy, together with chemotherapy Nursing Practice Standards (CCA 2006) these set out safe working practices, thereby protecting both patients and staff from the risks associated with the handling and administering of cytotoxic drugs. By following national and local guidelines the nurse also has a professional duty to adhere to their Code Of Conduct devised by the Nursing and Midwifery Council (NMC 2008) to provide a high standard of practice and care at all times, based on the best available evidence or best practice. (NMC 2008). States the nurse for their practice and should work within the limits of their competence. Therefore effective training and having a working knowledge of the (NMC 2004) Guidelines for the administration of medicines the nurse will be familiar with the chemotherapy drugs and their side effects and toxicities, which may range from an acute reaction to one that manifests days or weeks after treatment. The nurse will have the ability to provide effective support and treatment for the patient presenting with the symptoms described in the given question. This would lead me to suspect the possibility of an underlying infection, probably from the Hickman line. Infection is the leading complication associated with central venous catheters (CCA 2006) and an important cause of mortality in cancer patients (Viscoli 1998 p65) This is classed as a clinical emergency and requires immediate intervention preventing life threatening complications. In order to provide a high standard patient centred care, an adequate holistic assessment should be carried out with the patient and carer. In doing so the nurse can communicate affectively with the patient


References: Allwood, M. Stanley, A and Wright, P. (2002) The Cytotoxics Handbook. 4Th ed. Oxford: Rawcliffe Medical Press Limited. Cancer Care Alliance (2006) Chemotherapy Nursing Pratice Standards. Clinical Practice Guidelines. London: Cancer Care Alliance. Cancer Care Alliance (2006) Teaching Pack, A resource for chemotherapy education. Clinical Practice Guidelines London: Cancer Care Alliance. Grundy, M. (2000) Nursing in Haematological Oncology. London: Bailliere Tindall. Howard, M. and Hamilton, P. (1997) Haematology An Illustrated Colour Text. London: Churchill Livingstone Mallett, J Nursing and Midwifery Council (2005) Guidelines for the administration of medicines, London: Nursing and Midwifery Council. Nursing and Midwifery Council (2008) The code, Standards of conduct, performance and ethics for nurses and midwives. London: Nursing and Midwifery Council. Rolston, K.V (1999) New trends in patient management, risk-based therapy for febrile patients with Neutropenic Clinical Infectious Diseases 29 (3) 515-521. Royal College of Nursing (1998) Guidelines for cytotoxic chemotherapy – Clinical Practice Guidelines London: Scutari Projects. Simon, A.Bode, U. and Beutal, K. (2006) Diagnosis and treatment of catheters – related infections in paediatric oncology: Clinical Microbiology and Infection 12 (7) p606-620. Viscoli, C. (1998) The evolution of the empirical management of fewer and neutropenia in cancer patients, Journal of Antimicrobial Chemotherapy, 41, p65.

You May Also Find These Documents Helpful

  • Powerful Essays

    Preexisting myelosuppression or low hematologic cell counts are contraindications to the use of this drug, particularly in patients with rheumatoid arthritis or psoriasis. Close monitoring of the CBC is mandatory. Profound count nadirs may require therapy discontinuation, at least temporarily. Folate therapy and/or leucovorin rescue may be preventive or palliative. Treated patients who become febrile should be assumed to have neutropenia until proven otherwise.…

    • 2287 Words
    • 10 Pages
    Powerful Essays
  • Good Essays

    The problem this study was conducted to resolve appears to revolve around the fact that most chemotherapy treatments for cancer patients are done on an outpatient basis and that oncology nurses are faced with the challenge of providing The an overwhelming amount of basic information on the drugs, potential side effects, and measures to alleviate side effects in a limited amount of time. More of the problem would seem to be if the phone calls are made to patients as well as assessing their self-care agency levels before chemotherapy assists in better outcomes. This is an important problem for nursing to study in that implementing the interventions of phone calls, and pre-assessment could have direct impact on patient outcomes and the minimization of side effects of chemotherapy for breast cancer patients.…

    • 925 Words
    • 4 Pages
    Good Essays
  • Good Essays

    For over 40 years febrile neutropenia (FN) has been recognized as a significant risk factor in developing life-threatening infections in cancer patients receiving myelotoxic antineoplastic agents.1 FN is often defined as neutropenia (an absolute neutrophil count less than 500 cells/mm3) in the presence of a single oral temperature of ≥ 101°F or a temperature ≥ 100.4°F sustained for one hour or longer.2 Despite advances in antimicrobial treatment and management, mortality rates in cancer patients due to neutropenic related infections remain as high as X.3…

    • 992 Words
    • 4 Pages
    Good Essays
  • Best Essays

    Epirubicin

    • 4207 Words
    • 17 Pages

    Journal of Clinical Oncology 2001;19(8):2222-31. 48. Venturini M, Lunardi G, Del Mastro L, et al. Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity. Journal of Clinical Oncology 2000;18(10):2116-25. 49. Rose BD editor. Antineoplastic Agents (Anthracycline)/Trastuzumab. Waltham, Massachusetts: UpToDate®; accessed 15 December 2005. 50. Hospira Healthcare Corporation. Doxorubicin hydrochloride for injection® product monograph. Saint-Laurent, Quebec; 18 February 2008. 51. Pharmacia Limited. Pharmorubicin Solution for Injection® product monograph. Sandwich, Kent (United Kingdom); 15 September 2010. 52. Actavis UK Ltd. Epirubicin hydrochloride 50 mg powder for injection or infusion® product monograph. Barnstaple, Devon (United Kingdom); 12 April 2011. 53. Hospira UK Ltd. Epirubicin hydrochloride injection® product monograph. Royal Leamington Spa, Warwickshire; 23 August 2010. 54. medac GmbH. Epirubicin hydrochloride for injection® product monograph. Hamburg, Germany; 18 August 2010. 55. Josephine Holmes. Personal communication. Manager Regulatory Affairs, Pharmaceutical Partners of Canada Inc.; 12 June 2009. 56. BC Cancer Agency Breast Tumour Group. (BRAJFEC) BCCA Protocol Summary for Adjuvant Therapy for Breast Cancer Using Fluorouracil, Epirubicin and Cyclophosphamide. Vancouver, British Columbia: BC Cancer Agency; 2005. 57. BC Cancer Agency Breast Tumour Group. (BRAJCEF) BCCA Protocol summary for Adjuvant Therapy for Breast Cancer Using Cyclophosphamide, Epirubicin and Fluorouracil . Vancouver, British Columbia: BC Cancer Agency; 2005. 58. BC Cancer Agency Breast Tumour Group. (BRINFCEF) BCCA Protocol Summary of Therapy for Inflammatory Breast Cancer Using Cyclophosphamide, Epirubicin and Fluorouracil. Vancouver, British Columbia: BC Cancer Agency; 2005. 59. BC Cancer Agency Breast Tumour Group. (BRLACEF) BCCA Protocol Summary of Therapy for Locally Advanced Breast Cancer Using Cyclophosphamide, Epirubicin and Fluorouracil. Vancouver, British Columbia: BC Cancer Agency; 2005. 60. BC Cancer Agency Breast Tumour Group. (BRAJCEFG) BCCA Protocol Summary for Adjuvant Therapy for Breast Cancer Using Cyclophosphamide, Epirubicin, Fluorouracil and Filgrastim (G-CSF). Vancouver, British Columbia: BC Cancer Agency; 2005. 61. BC Cancer Agency Breast Tumour Group. (BRINFCEFG) BCCA Protocol Summary of Therapy for Inflammatory Breast Cancer Using Cyclophosphamide, Epirubicin, Fluorouracil and Filgrastim (G-CSF). Vancouver, British Columbia: BC Cancer Agency; 2005. 62. BC Cancer Agency Breast Tumour Group. (BRLACEFG) BCCA Protocol Summary of Therapy for Locally Advanced Breast Cancer Using Cyclophosphamide, Epirubicin, Fluorouracil and Filgrastim (G-CSF). Vancouver, British Columbia: BC Cancer Agency; 2005.…

    • 4207 Words
    • 17 Pages
    Best Essays
  • Powerful Essays

    According to the National Cancer Institute, approximately 12.7 million people are diagnosed with cancer each year and 7.6 million of them die from this disease. People usually undergo chemotherapy, radiation therapy, immunotherapy and some go towards alternative treatment to prolong their life, ameliorate it or even save it. Lately, there has been a high number of patients who have refused to pursue chemotherapy even though there was a high chance of improvement…

    • 1674 Words
    • 7 Pages
    Powerful Essays
  • Good Essays

    OSTEOSARCOMA

    • 2636 Words
    • 11 Pages

    Cancer is not a single disease with a single disease with a single cause; rather, it is a group of distinct diseases with different causes, manifestations, treatments, and prognoses. Cancer, nursing practice covers all age groups and nursing specialties and is carried out in a variety of heath care settings, including the home, community, acute care institutions, outpatient centers, rehabilitation and goals of cancer nursing, also called oncology nursing, are diverse and complex as those of any nursing specialty. Because many people associate cancer with pain and death, nurses need to identify their own reactions to cancer and set realistic goals to meet the challenges inherent in caring for patients with cancer. In addition, cancer nurses must be prepared to support patients and families through a wide range of physical, emotional, social, cultural, and spiritual crises.…

    • 2636 Words
    • 11 Pages
    Good Essays
  • Good Essays

    Diversity Research Paper

    • 830 Words
    • 4 Pages

    Balducci, Janine. (2003). Older Cancer Patient: A Guide for Nurses and Related Professionals. New York, NY: Springer Publishing Company.…

    • 830 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Chemotherapy

    • 1078 Words
    • 5 Pages

    Chemotherapy is known to have many negative side effects on all different parts of the body. Your hair falls out and your body becomes weak, but what effect does it have on your liver? This paper explores the effects chemo has on a person by review of scientific articles and experiments.…

    • 1078 Words
    • 5 Pages
    Powerful Essays
  • Good Essays

    Chemotherapy is the process of using various chemicals to treat diseases such as cancer. This process can be delivered by infusion through a catheter, by injection, or in tablet form. These chemicals target the cause of the disease and try to kill it off. In the case of cancer, toxic substances are used to kill rapidly dividing cancer cells. These substances alter cancer cell division or DNA function and synthesis (“Chemotherapy”). However, chemotherapy is very controversial as there is a lot of question about whether it’s worth going through or not. Over the course of my 15 years of life, I have known several people, some of which are family members, who have gone through chemotherapy. All of which have not survived more than…

    • 1484 Words
    • 6 Pages
    Good Essays
  • Powerful Essays

    Jamieson E, McCail J, Whyte L (2002) Clinical Nursing Practices: Guidelines for Nursing and Midwifery Council (200/) Evidence-Based Practice. Fourth edition, Standards fur Medicines Management Churchill Livingstone, Edinburgh, NMC, London, King L (2003) Subcutaneous insulin injecPratt RJ, Pellowe CM, Wilson JA et al tion technique. Nursing Standard. 17 34, (2007) epic2: national 45-52 evidence-based guidelines for preventing healthcare-associated infections in NHS Lister 5, Sarpal N (2004) Drug admitiis-…

    • 4087 Words
    • 117 Pages
    Powerful Essays
  • Good Essays

    Docetaxel Case Study

    • 889 Words
    • 4 Pages

    In one patient on doublet chemotherapy (Doceaqualip + Carboplatin) for non-small cell lung cancer, febrile neutropenia was encountered after the 3rd cycle chemotherapy. This patient recovered after receiving 6 doses of 300 µg Neukine on daily basis.…

    • 889 Words
    • 4 Pages
    Good Essays
  • Good Essays

    Tocilizumab Case Study

    • 1074 Words
    • 5 Pages

    The other estimated odds for infection were not significantly different for the 4 mg/kg dose group compared with controls and for the 8 mg/kg dose group compared with the 4 mg/kg dose group .Patients taking monotherapy were estimated to have odds approximately 0.94 times those of the control for developing at least one infection.…

    • 1074 Words
    • 5 Pages
    Good Essays
  • Powerful Essays

    Posaconazole Case Study

    • 1231 Words
    • 5 Pages

    2. Research by: Al-Badriyeh D, Slavin M, Liew D, et al. Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia. Journal of Antimicrobial Chemotherapy. 2010; 65(5): 1052-61…

    • 1231 Words
    • 5 Pages
    Powerful Essays
  • Powerful Essays

    Sitzia, J., & Dikken, C. (1997). Survey of the incidence and severity of side-effects reported by patients receiving six cycles of FEC chemotherapy . Journal of Cancer Nursing vol(1), 61-73.…

    • 5729 Words
    • 23 Pages
    Powerful Essays
  • Good Essays

    Discoveries

    • 936 Words
    • 3 Pages

    Dr Charlotte Willans who is leading the study said: "As many are unfortunately aware, chemotherapy can be a very gruelling experience for the patient. Finding effective, yet non-toxic drugs is an ongoing problem, but these preliminary results are an important step in solving it."…

    • 936 Words
    • 3 Pages
    Good Essays